The current price of GOSS is $9.95 — it has increased by 7.22% since the previous close. Data as of Nov 4, 2026.
GOSS is down 5.78% over the past week, down 7.10% over the past month and down 94.59% over the past year. The price is below its 200-day moving average of $39.28.
Analysts' average 12-month price target for GOSS is $3.47, which implies 65.13% downside from the current price. Individual estimates range from $0.30 to $9.00.
Of the 8 analysts covering Gossamer Bio, Inc., 1 rates it a strong buy, 3 rate it a buy, 3 rate it a hold and 1 rates it a strong sell. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.
Gossamer Bio, Inc. has a market capitalization of $60.8M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Gossamer Bio, Inc. posted a loss of $6.40 per share against an estimate of -$9.87, beating expectations by 35.16%. Upcoming reports are listed in the earnings calendar.
Gossamer Bio, Inc. reported revenue of $9.24M in its most recent quarter, which has decreased by 19.59% compared with the same quarter a year earlier. Analysts had expected $3.63M.
Gossamer Bio, Inc. has not paid any dividends over the past year.
Companies most comparable to Gossamer Bio, Inc. include RAPT Therapeutics, Inc., KalVista Pharmaceuticals, Inc., Ventyx Biosciences, Inc., Rigel Pharmaceuticals, Inc. and Corvus Pharmaceuticals, Inc.
In the latest trading session GOSS moved between $9.42 and $10.05, a range of 6.33% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Gossamer Bio, Inc. shows a neutral rating today and a sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Gossamer Bio, Inc. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks GOSS has traded between $8.29 and $309.60. The current price is 96.79% below its 52-week high.
Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.